Bedside Silo Versus Operative Closure for Gastroschisis

Status Terminated

Clinical Trial Summary

The hypothesis is that there is no difference between bedside silo placement and operative closure in return of bowel function, ventilator dependence, or length of stay.

The primary outcome variable between the two techniques will be determined from this study that can then be used to develop a definitive study. The likely variables will be length of time to meet discharge criteria, length of hospitalization, time to full feedings, time on mechanical ventilation and total hospital charges.

Clinical Trial Description

A strategy of blocked randomization will be utilized. The randomization will be blocked in groups of 4. Randomization sequence will be kept by the principal investigator. After permission is obtained, the next assignment will be obtained. This method assures that the physician obtaining permission will be blind to the treatment group.

The treatment groups will consist of the same medical management, feeding regimen and discharge criteria.

The interventions will be either bedside silo or operative attempt at closure. During attempt at primary closure, the abdomen will be closed completely if the staff anesthesiologist and surgeon agree the belly is not too tight based on ventilatory parameters, vital signs and appearance. If either the surgeon or anesthesiologist should feel the closed abdomen is too tight, a ringed silo will be placed in the operating room, the same silo used in the bedside treatment arm, and the child will continue in the study. When a silo is placed either in the operating room due to inability to close the abdomen or at the bedside, they will be managed the same way. The skin will be dressed in the standard fashion (betadine jelly, xeroform and kerlix). The dressing allows visualization of the bowel. No reductions will be done the day of placement. After one night of observation a tie will be gently placed to apply downward pressure on the bowel. This pressure will not be allowed to increase the peak ventilator pressure by more than 2 cm H2O. One tie will be placed each subsequent day until the tie is within 2 cm of the skin at which point the patient will be scheduled for operative closure the day following the placement of the tie.

The medical management is controlled for resuscitation, sedation, ventilation and feeding between groups. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Gastroschisis

Clinical Trial Details

NCT number	NCT00404690
Study type	Interventional
Source	Children's Mercy Hospital Kansas City
Contact
Status	Terminated
Phase	N/A
Start date	October 2006
Completion date	October 2008

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00539292` - Evaluating the Use of a Silastic Spring-Loaded Silo for Infants With Gastroschisis	Phase 2
Recruiting	`NCT03724214` - Multi-Centre Gastroschisis Interventional Study Across Sub-Saharan Africa	N/A
Recruiting	`NCT01469208` - Music Therapy: An Adjunct To Gastroschisis Infants' Care	N/A
Recruiting	`NCT05704257` - Fetal Repair of Complex Gastroschisis: A Safety and Feasibility Trial	N/A
Completed	`NCT03533439` - Regional Blood Saturation Levels in Gastroschisis
Active, not recruiting	`NCT03393832` - Oral Care in Infants With Gastroschisis
Completed	`NCT03666767` - Management and Outcomes of Congenital Anomalies in Low-, Middle- and High-Income Countries
Terminated	`NCT03355326` - Evaluation of Glycerin Suppositories to Improve Bowel Function in Gastroschisis	Phase 4
Completed	`NCT03185637` - Children's Surgery in Sub-Saharan Africa	N/A
Completed	`NCT02575846` - Clinical and Biological Outcomes of Human Milk and Formula Intake After Gastroschisis Repair	N/A
Terminated	`NCT01094587` - Sutureless vs Sutured Gastroschisis Closure	N/A
Active, not recruiting	`NCT00127946` - Trial of AMNIOECHANGE in Gastroschisis Affected Foetuses	Phase 3
Withdrawn	`NCT04186039` - Functional Evaluation of the Fetal Lung by Functional Magnetic Resonance Imaging - Blood Oxygenation Level Dependent (MRI-BOLD), in Congenital Diaphragmatic and Parietal Malformations	N/A
Completed	`NCT03960320` - Health Related Quality of Life of Patients With Abdominal Wall Defects
Terminated	`NCT02098915` - Metoclopramide Pilot Trial	Phase 3
Completed	`NCT01316510` - Probiotics in Infants With Gastroschisis	N/A
Completed	`NCT04020939` - The Role of Indocyanine Green Angiography Fluorescence on Intestinal Resections in Pediatric Surgery.	N/A
Recruiting	`NCT06072976` - The Influence of Feeding Source on the Gut Microbiome and Time to Full Feeds in Neonates With Congenital Gastrointestinal Pathologies	N/A
Recruiting	`NCT05293353` - Neokare Safety and Tolerability Assessment in Neonates With GI Problems
Completed	`NCT02370251` - Compassionate Use of Omegaven in Children	Phase 2/Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.